Series A - Dxcover

Series A - Dxcover

Investment Firm

Overview

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

Announced Date

Feb 01, 2023

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorNorcliffe Capital
Participant InvestorUniversity of Strathclyde
Participant InvestorMercia Fund Managers
Participant InvestorMark Bamforth
Participant InvestorScottish Enterprise

Round Details and Background

Dxcover raised $9290745 on 2023-02-01 in Series A

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 28, 2019
Grant - Dxcover
1-undefined
Feb 11, 2019
Grant - Dxcover
2-undefined
Dec 21, 2022
Grant - Dxcover
1-2.7M
Feb 01, 2023
Series A - Dxcover
7-9.3M

Recent Activity

There is no recent news or activity for this profile.